Issues related to implementation of US-Korea Free Trade Agreement
Issues related to trade protections in Trans Pacific Partnership
Discussions regarding US-EU Trade Liberalization Agreement Issues related to reform of tax code and possible timing of any such reform bill (no bill number yet) HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration
Issues related to the Medicaid rebate formula H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144  issues related to the development of antibiotics
S. 27 and related legislative proposals regarding possible restrictions on patent settlements
HR 6353 and related legislative proposals regarding possible changes to tax law regarding intellectual property profits H.R. 6621 and related legislative proposals regarding technical fixes in patent reform H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144  issues related to the development of antibiotics
Issues related to drug safety, supply chain, and facility inspections (No assigned legislation)
Issues related to federal purchases under the Trade Agreements Act HR 6611 and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting
Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to drug safety, supply chain, and facility inspections (No assigned legislation)
HR 6611 and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes HR 1513, S 810 and related legislative proposals regarding the use of primates in clinical research
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark HCR - Health Issues CSP - Consumer Issues/Safety/Products PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
BRADLEY ALLEN ROSSIN HEATHER STRAWN BRADLEY ALLEN ROSSIN THERESA JOLIVETTE ANDREW KAPLAN BELA SASTRY HEATHER STRAWN JACQUELINE POMFRET KIRBY CARRIE HARNEY THERESA JOLIVETTE ANDREW KAPLAN CARRIE HARNEY THERESA JOLIVETTE ANDREW KAPLAN BELA SASTRY JACQUELINE POMFRET KIRBY HEATHER STRAWN CARRIE HARNEY THERESA JOLIVETTE ANDREW KAPLAN HEATHER STRAWN HEATHER STRAWN CARRIE HARNEY ANDREW KAPLAN HEATHER STRAWN